Related Experiment Video
Updated: May 26, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Phialemonium curvatum fungaemia in an immunocompromised patient: case report
B Persy1, I Vrelust, A Gadisseur
1Laboratory of Microbiology, University Hospital of Antwerp, Edegem, Belgium. ben.persy@telenet.be
Abstract:
Although infections due to fungal pathogens are rare, the incidence of such infections has increased over the last few decades, mainly because of growing populations of immunocompromised patients. We report a case of a Phialemonium curvatum fungaemia in a woman with a history of a peripheral stem-cell transplantation. The case is analysed with 20 other cases described in the literature since 1986. Adequate therapeutic management is becoming increasingly important for immunode-pressed patients, in light of a broadened therapeutic choice of antifungals. Therefore precise and timely identification of fungi is needed. Therapeutic options with regard to Phialemonium fungaemia are also discussed.
Insights
Fungal infections like Phialemonium curvatum are rising in immunocompromised individuals. Early diagnosis and antifungal treatment are crucial for managing these rare but serious fungaemias.
Area of Science:
- Mycology
- Infectious Diseases
- Hematology
Background:
- Fungal infections are increasing, particularly in immunocompromised patients.
- Phialemonium curvatum is a rare fungal pathogen.
- Peripheral stem-cell transplantation (PSCT) increases susceptibility to infections.
Observation:
- A case of Phialemonium curvatum fungaemia in a woman post-PSCT is presented.
- This case is analyzed alongside 20 previously reported cases since 1986.
- The patient's clinical presentation and treatment are detailed.
Findings:
- Phialemonium curvatum fungaemia requires precise and timely fungal identification.
- Analysis of 21 cases highlights the challenges in diagnosing and treating this infection.
- The study reviews available therapeutic options for Phialemonium fungaemia.
Implications:
- Improved diagnostic methods are essential for effective management of rare fungal infections.
- Expanded antifungal choices necessitate careful consideration for immunocompromised patients.
- This case underscores the importance of vigilance for fungal pathogens in susceptible populations.
Related Concept Videos
Fungal Phylum Microsporidia
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Fungal Phylum Ascomycota
Fungal Group Zygomycota
Fungal Phylum Basidiomycota
